Showing 241 - 260 results of 32,533 for search '(( 5 ((mg decrease) OR (nn decrease)) ) OR ( 50 ((ns decrease) OR (a decrease)) ))', query time: 0.92s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244

    Features and Consequences of Isopropanol Burning off PTFE–rGO Aerogels by Sergey A. Baskakov (11324315)

    Published 2021
    “…An improved procedure for the preparation of aerogel granules of polytetrafluoroethylene–graphene oxide (PTFE–GO) with a composition of 50:50 (in wt %) and a specific density of 35 ± 2 mg/cm<sup>3</sup> is described. …”
  5. 245
  6. 246
  7. 247
  8. 248
  9. 249
  10. 250

    Topography of the relationship between the change in alpha power decrease and the change in M50 gating ratio. by Tzvetan Popov (315385)

    Published 2013
    “…B: Relationship between change in alpha power decrease (abscissa, negative values indicate improvement) and pre-to-post-training change in M50 gating ratio (ordinate, positive values indicate changes towards normal, that is, smaller gating ratio) by patient training group based on the ROI in 4A.…”
  11. 251
  12. 252
  13. 253
  14. 254
  15. 255
  16. 256

    Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

    Published 2016
    “…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”
  17. 257
  18. 258
  19. 259

    Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy by Yong-Chul Kim (1637572)

    Published 2013
    “…The pre-defined secondary outcomes were better in the Tac group compared to the control group. The frequency of decrease in pcUACR and percentage change of UPCR (pcUPCR) ≥50% at 16 weeks were 65.0% (13/20) and 55.0% (11/20)in the Tac group, and 25.0% (5/20) and 15.0% (3/20), in the control group, respectively (p = 0.025 for pcUACR and p = 0.019 for pcUPCR). …”
  20. 260